These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 16443242

  • 1. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence.
    Célérier E, Ahdepil T, Wikander H, Berrendero F, Nyberg F, Maldonado R.
    Neuropharmacology; 2006 Jun; 50(7):788-806. PubMed ID: 16443242
    [Abstract] [Full Text] [Related]

  • 2. Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC.
    Soria G, Castañé A, Berrendero F, Ledent C, Parmentier M, Maldonado R, Valverde O.
    Eur J Neurosci; 2004 Oct; 20(8):2203-13. PubMed ID: 15450100
    [Abstract] [Full Text] [Related]

  • 3. Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects.
    Rubino T, Forlani G, Viganò D, Zippel R, Parolaro D.
    J Neurochem; 2005 May; 93(4):984-91. PubMed ID: 15857401
    [Abstract] [Full Text] [Related]

  • 4. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K, Mishima K, Hazekawa M, Sano K, Irie K, Orito K, Egawa T, Kitamura Y, Uchida N, Nishimura R, Egashira N, Iwasaki K, Fujiwara M.
    Brain Res; 2008 Jan 10; 1188():157-64. PubMed ID: 18021759
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Behavioral effects of the novel cannabinoid full agonist AM 411.
    McLaughlin PJ, Lu D, Winston KM, Thakur G, Swezey LA, Makriyannis A, Salamone JD.
    Pharmacol Biochem Behav; 2005 May 10; 81(1):78-88. PubMed ID: 15894067
    [Abstract] [Full Text] [Related]

  • 9. Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways.
    Verhoeckx KC, Korthout HA, van Meeteren-Kreikamp AP, Ehlert KA, Wang M, van der Greef J, Rodenburg RJ, Witkamp RF.
    Int Immunopharmacol; 2006 Apr 10; 6(4):656-65. PubMed ID: 16504929
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of nandrolone on acute morphine responses, tolerance and dependence in mice.
    Célérier E, Yazdi MT, Castañé A, Ghozland S, Nyberg F, Maldonado R.
    Eur J Pharmacol; 2003 Mar 28; 465(1-2):69-81. PubMed ID: 12650835
    [Abstract] [Full Text] [Related]

  • 13. Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion.
    Gorriti MA, Ferrer B, del Arco I, Bermúdez-Silva FJ, de Diego Y, Fernandez-Espejo E, Navarro M, Rodríguez de Fonseca F.
    Pharmacol Biochem Behav; 2005 May 28; 81(1):71-7. PubMed ID: 15894066
    [Abstract] [Full Text] [Related]

  • 14. Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.
    Valjent E, Mitchell JM, Besson MJ, Caboche J, Maldonado R.
    Br J Pharmacol; 2002 Jan 28; 135(2):564-78. PubMed ID: 11815392
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity.
    Singh ME, McGregor IS, Mallet PE.
    Neuropharmacology; 2005 Dec 28; 49(8):1189-200. PubMed ID: 16137723
    [Abstract] [Full Text] [Related]

  • 19. The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol.
    Verty AN, McGregor IS, Mallet PE.
    Brain Res; 2004 Sep 10; 1020(1-2):188-95. PubMed ID: 15312802
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological characterization of cannabinoids in the elevated plus maze.
    Onaivi ES, Green MR, Martin BR.
    J Pharmacol Exp Ther; 1990 Jun 10; 253(3):1002-9. PubMed ID: 2162942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.